Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Winder

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|May 21, 1999
Latent dysbetalipoproteinaemia precipitated by HIV-protease inhibitorsR K Lister, M Youle, D R Nair, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 15, 1995
A trinucleotide deletion together with a base duplication event at codon 439 in the human tyrosinase gene identifies a mutational hotspotL H Breimer, A F Winder, P Panayiotidis, et al.
Clinical Chemistry|October 1, 1994
Is bilirubin protective against coronary artery disease?L H Breimer, K A Spyropolous, A F Winder, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|April 1, 1988
Surface tension properties of human urine: relationship with bile salt concentrationC O Mills, E Elias, G H Martin, et al.
Clinical Chemistry|November 1, 1995
High-throughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresisM K Bolla, L Haddad, S E Humphries, et al.
American Journal of Hypertension|July 20, 1999
Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemiaJ A Papadakis, E S Ganotakis, I A Jagroop, et al.
Lancet (London, England)|May 21, 1998
Statins and fibrinogenD R Nair, J A Papadakis, I A Jagroop, et al.
International Journal of Cardiology|July 13, 1999
Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular diseaseJ A Papadakis, E S Ganotakis, I A Jagroop, et al.
Lancet (London, England)|May 27, 1989
Detection of asymptomatic coronary artery disease in familial hypercholesterolaemiaA P Wojciechowski, L O Hughes, E B Raftery, et al.
Journal of Clinical Pathology|May 1, 1996
The pathology of cornea in Tangier disease (familial high density lipoprotein deficiency)A F Winder, R Alexander, A Garner, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|May 21, 1999
Latent dysbetalipoproteinaemia precipitated by HIV-protease inhibitorsR K Lister, M Youle, D R Nair, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 15, 1995
A trinucleotide deletion together with a base duplication event at codon 439 in the human tyrosinase gene identifies a mutational hotspotL H Breimer, A F Winder, P Panayiotidis, et al.
Clinical Chemistry|October 1, 1994
Is bilirubin protective against coronary artery disease?L H Breimer, K A Spyropolous, A F Winder, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|April 1, 1988
Surface tension properties of human urine: relationship with bile salt concentrationC O Mills, E Elias, G H Martin, et al.
Clinical Chemistry|November 1, 1995
High-throughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresisM K Bolla, L Haddad, S E Humphries, et al.
American Journal of Hypertension|July 20, 1999
Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemiaJ A Papadakis, E S Ganotakis, I A Jagroop, et al.
Lancet (London, England)|May 21, 1998
Statins and fibrinogenD R Nair, J A Papadakis, I A Jagroop, et al.
International Journal of Cardiology|July 13, 1999
Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular diseaseJ A Papadakis, E S Ganotakis, I A Jagroop, et al.
Lancet (London, England)|May 27, 1989
Detection of asymptomatic coronary artery disease in familial hypercholesterolaemiaA P Wojciechowski, L O Hughes, E B Raftery, et al.
Journal of Clinical Pathology|May 1, 1996
The pathology of cornea in Tangier disease (familial high density lipoprotein deficiency)A F Winder, R Alexander, A Garner, et al.
Pageof 10